Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immune evader cancer stem cells direct the perspective approaches to cancer immunotherapy
Hassan Dianat‐Moghadam, Amir Mahari, Reza Salahlou, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Unveiling the mechanisms and challenges of cancer drug resistance
Sameer Ullah Khan, Kaneez Fatima, Shariqa Aisha, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 91
Characteristics of the cancer stem cell niche and therapeutic strategies
Feng Ju, Manar Atyah, Nellie Horstmann, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 77
Recent Advances and Challenges in Cancer Immunotherapy
Chelsea Peterson, Nathan Denlinger, Yiping Yang
Cancers (2022) Vol. 14, Iss. 16, pp. 3972-3972
Open Access | Times Cited: 75
Histone modifications in drug-resistant cancers: From a cancer stem cell and immune evasion perspective
Ming Jin, Kwang Won Jeong
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 7, pp. 1333-1347
Open Access | Times Cited: 29
Biomaterial-based platforms for modulating immune components against cancer and cancer stem cells
Nimeet Desai, Uzma Hasan, K Jeyashree, et al.
Acta Biomaterialia (2023) Vol. 161, pp. 1-36
Open Access | Times Cited: 24
Omics approaches: Role in acute myeloid leukemia biomarker discovery and therapy
Fatemeh Sadat Shafiei, Saeid Abroun, Sadaf Vahdat, et al.
Cancer Genetics (2025) Vol. 292-293, pp. 14-26
Closed Access | Times Cited: 1
Deciphering the Role of Cancer Stem Cells: Drivers of Tumor Evolution, Therapeutic Resistance, and Precision Medicine Strategies
Mohamed El‐Tanani, Syed Arman Rabbani, Shakta Mani Satyam, et al.
Cancers (2025) Vol. 17, Iss. 3, pp. 382-382
Open Access | Times Cited: 1
Engaging stemness improves cancer immunotherapy
Hassan Dianat‐Moghadam, Mohammadreza Sharifi, Rasoul Salehi, et al.
Cancer Letters (2022) Vol. 554, pp. 216007-216007
Closed Access | Times Cited: 37
Targeting CD24 as a novel immunotherapy for solid cancers
Yan Yang, Guangming Zhu, Li Yang, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 22
Targeting cancer stem cells as a strategy for reducing chemotherapy resistance in head and neck cancers
Dawid Dorna, Jarosław Paluszczak
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 14, pp. 13417-13435
Open Access | Times Cited: 19
Dendritic cells and natural killer cells: The road to a successful oncolytic virotherapy
Matin Ghasemi, Laleh Abbasi, Leila Ghanbari Naeini, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 17
Molecular Biomarkers and Signaling Pathways of Cancer Stem Cells in Colorectal Cancer
Mohamed M. Omran, Manar S. Fouda, Sara A. Mekkawy, et al.
Technology in Cancer Research & Treatment (2024) Vol. 23
Open Access | Times Cited: 6
Nanomedicines for Overcoming Cancer Drug Resistance
Tingting Hu, Hanlin Gong, Jiayue Xu, et al.
Pharmaceutics (2022) Vol. 14, Iss. 8, pp. 1606-1606
Open Access | Times Cited: 27
Targeting crosstalk of signaling pathways in cancer stem cells: a promising approach for development of novel anti-cancer therapeutics
Subhasmita Bhal, Chanakya Nath Kundu
Medical Oncology (2023) Vol. 40, Iss. 2
Closed Access | Times Cited: 14
Immunotherapies targeting tumor vasculature: challenges and opportunities
Hassan Dianat‐Moghadam, Reza Nedaeinia, Mohsen Keshavarz, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 14
Biomarkers and targeted therapy for cancer stem cells
Yusheng Liu, Hua Wang
Trends in Pharmacological Sciences (2023) Vol. 45, Iss. 1, pp. 56-66
Closed Access | Times Cited: 14
Sniping Cancer Stem Cells with Nanomaterials
Wen-Da Wang, Yanyu Guo, Zhonglu Yang, et al.
ACS Nano (2023) Vol. 17, Iss. 23, pp. 23262-23298
Closed Access | Times Cited: 12
Tumor initiating cells escape tumor immunity via CCL8 from tumor-associated macrophages in mice
Shuang Chen, Chen‐Song Huang, Kang Li, et al.
Journal of Clinical Investigation (2025)
Open Access
Biomedical engineering targeting cancer stem cells to reinforce cancer therapy
Shumin Sun, Nailin Yang, Zifan Pei, et al.
Coordination Chemistry Reviews (2025) Vol. 530, pp. 216494-216494
Closed Access
Single-cell profiling reveals the intratumor heterogeneity and immunosuppressive microenvironment in cervical adenocarcinoma
Yang Peng, Jing Yang, Jixing Ao, et al.
eLife (2025) Vol. 13
Open Access
Therapeutic and prognostic values of ferroptosis signature in glioblastoma
Reza Nedaeinia, Hassan Dianat‐Moghadam, Maedeh Movahednasab, et al.
International Immunopharmacology (2025) Vol. 155, pp. 114597-114597
Closed Access
LXR inhibitor SR9243-loaded immunoliposomes modulate lipid metabolism and stemness in colorectal cancer cells
Hassan Dianat‐Moghadam, Soheil Abbaspour‐Ravasjani, Hamed Hamishehkar, et al.
Medical Oncology (2023) Vol. 40, Iss. 6
Closed Access | Times Cited: 9
Interplay among extracellular vesicles, cancer stemness and immune regulation in driving hepatocellular carcinoma progression
Yu‐Man Tsui, Lü Tian, Jingyi Lu, et al.
Cancer Letters (2024) Vol. 597, pp. 217084-217084
Open Access | Times Cited: 3
The missing link between cancer stem cells and immunotherapy
Lobna Safwat Ali, Youssef Attia, Sohaila Mourad, et al.
Current Medical Research and Opinion (2024), pp. 1-35
Closed Access | Times Cited: 3
Artificial intelligence-based comprehensive analysis of immune-stemness-tumor budding profile to predict survival of patients with pancreatic adenocarcinoma
Tianxing Zhou, Quan Man, Xueyang Li, et al.
Cancer Biology and Medicine (2023) Vol. 20, Iss. 3, pp. 196-217
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top